Powered by etc. Ventures
Transform Your IP
The Station 41 Venture Studio is seeking licensing and commercialization partners to advance biotech products through non-dilutive and equity funding.
Station 41 Venture Studio provides technology programs with the corporate structure and resources to advance further via non-dilutive and equity funding. The Venture Studio was launched by SR in 2022, which implemented a program prioritization rubric using commercial, regulatory, and scientific diligence processes aligned to venture capital standards.
The Venture Studio will launch three cohorts annually, aligned to NIH non-dilutive funding deadlines. In addition to seeding and prioritizing further development of core technologies, the Venture Studio Director and team will launch a business development and marketing function for the spinout entity, including creation of a corporate brand, website, and relevant marketing assets.
Ideal venture studio programs are aligned with Southern Research’s therapeutic development expertise:
Venture Studio Companies
The Post Grid block on this page is invisible because it has been hidden so that it can be overridden by a Kadence Element. Please edit the layout in Appearance > Kadence Elements.
"*" indicates required fields